Clinical trials
Phase 2 Neoplasms trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tampere University Hospital | 2 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| GW Pharmaceuticals Ltd | 1 |
| Hoffmann-La Roche | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Oslo University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 11 |
| Breast Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Recurrence | 2 |
| Blood Protein Disorders | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Constipation | 1 |
| Hematologic Diseases | 1 |
| Immunoproliferative Disorders | 1 |
| Intestinal Diseases | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.